News Releases

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010

2017 Archives

May 2, 2017
Teligent Revenue Growth of 27% Over 2016
Mar 7, 2017
51% Revenue Growth, 9 FDA Approvals and 5 U.S. Launches in 2016
Jan 3, 2017
Nystatin and Triamcinolone Acetonide Ointment USP, Clindamycin Phosphate Topical Solution USP, 1% and Flurandrenolide Ointment USP, 0.05%
 

print email rss